BF Biosciences Limited (PSX:BFBIO)

United States Steel Revenue

BF Biosciences had revenue of 1.50B PKR in the quarter ending March 31, 2025, with 41.22% growth. This brings the company's revenue in the last twelve months to 4.96B, up 40.05% year-over-year. In the fiscal year ending June 30, 2024, BF Biosciences had annual revenue of 3.66B with 102.19% growth.

• Revenue (ttm): 4.96B
• Revenue Growth: +40.05%
• P/S Ratio: 2.87
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 14.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	3.66B	1.85B	102.19%
Jun 30, 2023	1.81B	288.82M	18.99%
Jun 30, 2022	1.52B	-234.10M	-13.34%
Jun 30, 2021	1.75B	1.13B	179.30%
Jun 30, 2020	628.29M	179.82M	40.10%